Glenmark Pharmaceuticals Inc., USA is recalling approximately 32,472 bottles of Carvedilol (generic Coreg) tablets in 12.5 mg and 25 mg strengths. The recall was initiated because test results found an impurity called N-Nitroso Carvedilol Impurity-1 (NNCI) at levels that exceed the FDA-recommended limit. Affected products include 17,496 bottles of the 12.5 mg dose and 14,976 bottles of the 25 mg dose, all with an expiration date of June 2026.
The impurity found, NNCI, is a type of nitrosamine. While everyone is exposed to some nitrosamines, long-term exposure to levels above the recommended limit may increase the risk of cancer. To date, there have been no reports of illnesses or injuries related to this specific recall.
You have 2 options:
Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430
Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.